Fox Chase Cancer Center is among the first in the country to offer TIL (tumor-infiltrating lymphocyte) therapy for patients with metastatic melanoma who are no longer responding to standard treatments. This FDA-approved, one-time therapy uses a patient’s own bioengineered cells to fight cancer and requires a highly specialized, multidisciplinary team. Read more about our melanoma program and TIL therapy: https://bit.ly/46xKJz5
Fox Chase Cancer Center
Hospitals and Health Care
Philadelphia, PA 23,610 followers
Defeating cancer is our calling.
About us
At Fox Chase Cancer Center, defeating cancer is our calling. Fox Chase is one of the nation’s first dedicated cancer hospitals, and our researchers and physicians have made major contributions to scientific advancement since our establishment more than a century ago in 1904. Fox Chase scientists have made breakthroughs in cancer prevention, diagnosis, treatment, and survivorship, and have earned the highest awards in their fields, including two Nobel Prizes. We translate these pioneering discoveries into world-class clinical care every day - with a single purpose: to defeat cancer and help the people it impacts. This calling is rooted in our cancer-specific, multidisciplinary teams of doctors, researchers, practitioners, and five-time Magnet designated nurses, who are all more than specialists in cancer; they are international experts in distinct types of cancer, whose deep and focused expertise provides the best chance for the best outcome anywhere along the cancer continuum. And they’re helping to advance the way cancer treatment is delivered around the world. The way we work together, with this single, shared passion for our patients’ well-being, is what makes us truly unique. For more information, visit our website at FoxChase.org or call 888-FOX-CHASE (888-369-2427.)
- Website
-
http://www.foxchase.org
External link for Fox Chase Cancer Center
- Industry
- Hospitals and Health Care
- Company size
- 1,001-5,000 employees
- Headquarters
- Philadelphia, PA
- Type
- Nonprofit
- Founded
- 1904
- Specialties
- cancer, oncology, research, science, medical oncology, surgical oncology, radiation oncology, cancer prevention, diagnostic imaging, and Pathology
Locations
-
Primary
Get directions
333 Cottman Avenue
Philadelphia, PA 19111, US
-
Get directions
2365 Heritage Center Drive
Furlong, PA 18925, US
Employees at Fox Chase Cancer Center
Updates
-
Congratulations to Stefanie Murphy, appointed as Temple Health’s new SVP and Chief Marketing & Communications Officer — a true “Temple Made” leader driving our mission forward. #TempleMade #ItTakesTempleHealth
Temple Health is proud to announce the appointment of Stefanie Murphy as Senior Vice President and Chief Marketing & Communications Officer for Temple Health. Stefanie is a “Temple Made” leader with more than 17 years advancing through the Temple Health marketing department. Her steady rise reflects deep institutional insight, creative problem-solving, and a commitment to Temple’s mission. In this role, she will lead marketing, communications, key account management, and business development, aligning these functions to continue strengthening the organization’s reputation and advance our mission to expand access to care. With a forward-thinking approach and strategic use of emerging tools and technologies, Stefanie is well positioned to guide Temple Health’s growth and brand strategies in today’s dynamic healthcare environment. Please join us in congratulating Stefanie on this well-deserved appointment! #TempleMade #ItTakesTempleHealth
-
-
Meet Akina Tamaki, MD, FACS, a head and neck cancer surgeon at Fox Chase Cancer Center – Main Campus, part of Temple Health – Temple University Health System. Dr. Tamaki specializes in surgical treatment for head and neck cancers, offering compassionate, personalized care through a multidisciplinary cancer care team. She is committed to guiding patients and their families through surgery, recovery, and follow-up treatment with expertise and empathy. At Fox Chase, Dr. Tamaki continues the tradition of excellence in cancer care—helping patients access the most advanced treatments, clinical trials, and supportive services available. Learn more: https://bit.ly/435AqQu
Fox Chase Cancer Center | Akina Tamaki, MD, FACS | Head and Neck Cancer Surgeon
https://www.youtube.com/
-
We’re proud to welcome Dr. Lisa Bevilacqua, Thoracic Surgical Oncologist, to Fox Chase Cancer Center – Main Campus and Fox Chase – East Norriton. Dr. Bevilacqua treats patients with esophageal and lung cancers, neuroendocrine tumors, GIST, GERD and Barrett’s esophagus, thymoma, chest wall disease, and metastatic cancers to the lung. Her approach to care integrates evidence-based medicine and minimally invasive, robotic-assisted surgery with a strong commitment to patient education, empathy, and collaboration. She believes that trust and communication are just as important as surgical precision in achieving the best outcomes. Learn more: https://bit.ly/4mZusYz
Lisa Bevilacqua | Thoracic Surgical Oncologist
https://www.youtube.com/
-
Register now for the 2025 Practice-Changing Updates in Bladder, Kidney & Prostate Cancer CME program on October 23, 2025, hosted by Fox Chase Cancer Center and Temple Health – Temple University Health System. For more information, visit: https://bit.ly/GU2025CME
-
Fox Chase Cancer Center was proud to represent at American Society for Radiation Oncology (ASTRO) 2025 in San Francisco, where our team shared innovative research and clinical advancements in radiation oncology. One of the central themes of this year’s meeting was adaptive radiation therapy, and Fox Chase was at the forefront of that conversation. We are energized by the conversations, collaborations, and scientific breakthroughs shared throughout the week. To explore the full list of Fox Chase presentations and posters from ASTRO 2025, visit our recap page: https://bit.ly/3KGPttF #ASTRO25 #FoxChaseAtASTRO #RadiationOncology #CancerResearch
-
-
-
-
-
+3
-
-
Congratulations to Robert Uzzo, MD, MBA, FACS, whose new role will enhance our cancer care through integration and strengthen Fox Chase as an institution! #Leadership #CancerCare #FoxChaseCancerCenter #DiscoveryandDelivery #PhiladelphiasCancerCenter
We’re proud to announce that Robert Uzzo, MD, MBA, FACS’s role as President & CEO of Fox Chase Cancer Center now extends beyond the American Oncologic Hospital and includes the Institute for Cancer Research. This will unite Fox Chase’s dual missions of cancer care and research and unlock limitless possibilities for scientific advancement while broadening the institution’s impact well beyond our region. An internationally recognized urologic cancer surgeon and researcher, Dr. Uzzo has a proven track record of success at building and strengthening innovative research and academic programs. As President & CEO of Fox Chase Cancer Center, he has significantly advanced its clinical, research, operational, and financial performance, and further accelerated the pace of cancer discovery and delivery for our patients. Congratulations to Dr. Uzzo and Fox Chase on this exciting new chapter! #Leadership #CancerCare #FoxChaseCancerCenter #DiscoveryandDelivery #PhiladelphiasCancerCenter
-
-
Congratulations to Jeffrey Farma, MD, FACS, Chair and Professor in the Department of Surgery at Fox Chase Cancer Center, who has been elected to serve as the Society of University Surgeons (SUS) representative to the Association of American Medical Colleges’ (AAMC) Council of Faculty and Academic Societies (CFAS). Read more: https://bit.ly/4ngtqbD
-
For over 50 years, Fox Chase and West Pharmaceutical Services have worked together to reduce the burden of cancer. Partners like West help us discover better ways to deliver better care. West’s support of the new Fox Chase Mobile Screening Unit allows Fox Chase to go into communities and screen patients for cancer, catching cancer earlier and treating it more effectively. Patients who receive a cancer diagnosis can seamlessly be treated at Fox Chase. We’re proud to team up with Community Volunteers in Medicine (CVIM) and West to expand access to screenings and ensure that more patients receive the care they need. Together, we’re making a difference.
-
Please join us in welcoming Maureen Hill, MD, to Fox Chase Cancer Center. Dr. Hill is a Surgical Oncologist who sees patients at our Main Campus and Chestnut Hill locations. She believes that every patient’s journey is unique and uses their individual values and goals to create personalized treatment plans—from clinical trials to palliative care. Learn more: https://bit.ly/42lfRiL
Fox Chase Cancer Center | Maureen Hill, MD
https://www.youtube.com/